Alberto J. Schuhmacher

September 10, 2026

Aragon opens a new path against the most aggressive cancers with dromedary nanoantibodies

A team from the Aragon Health Research Institute is developing a technology capable of improving diagnosis, guiding surgeries, and delivering treatments directly to the tumor to reduce side effects.
August 14, 2026

Alberto Jiménez Schuhmacher highlights on Onda Cero the potential of the eclipse to awaken new scientific vocations

The researcher from IIS Aragón participated in the program "Por fin," where he shared his impressions of the eclipse and reflected on the importance of bringing science closer to society.
16 April 2026

The Tarazona Sentinel Association donates 40.000 euros to the IIS Aragón to promote new research projects

The 2025 charity race, in which more than 4.000 people participated, helped raise a significant portion of this donation. During the event, Alberto J. Schuhmacher presented the project funded in 2024 and the one planned for this year.
September 4, 2025

The Alliance Against Metastasis: Innovation and Support (ALMIA) is organizing an interesting roundtable discussion next Tuesday.

"Cancer and Metastasis Today: Challenges and Hope" will take place on September 9 at the Ibercaja Patio de la Infanta Foundation.
August 19, 2025

Sara Project at the IIS Aragón: the challenge of developing more potent and less harmful cancer drugs

Developed by the Molecular Oncology Group at the IIS Aragón, led by Alberto J. Schuhmacher, it is based on an innovative technology that uses nanobodies derived from dromedaries.
18 June, 2025

The IIS Aragón and the Ibercaja Foundation have signed an agreement to promote the innovative oncology research project "Sara."

This research, led by the Molecular Oncology Group at the IIS Aragón, aims to improve the efficacy of chemotherapy while significantly reducing its adverse effects. The signing of this agreement reinforces the commitment of both institutions to the advancement of cancer research in Aragon.